Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Bupivacaine in Hysterectomy
NCT02352922Phase 4Completed
- Sponsor
- AdventHealth
- Start
- Jul 2015
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by AdventHealth. Primary endpoint: Numerical Rating Scale Post-operative Pain Score at 24 hours. Started Jul 2015; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02352922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02352922.